Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bernhard

Showing results (171-180 of 250) with videos related to

Pageof 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
The measurement of bioreductive capacity of tumor cells using methylene blueJ E Biaglow, C J Koch, S W Tuttle, et al.
Cancer Research|May 8, 2007
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavirZibin Jiang, Nabendu Pore, George J Cerniglia, et al.
Cancer Research|February 24, 2001
Apoptosis: an early event in metastatic inefficiencyC W Wong, A Lee, L Shientag, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, A Ravaud, Y Grassano, et al.
Gastroenterology|July 6, 2004
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogeneFranz S Schreiber, Therese B Deramaudt, Thomas B Brunner, et al.
Cancer Research|September 20, 2006
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapyNabendu Pore, Anjali K Gupta, George J Cerniglia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, G Capon, G Pierquet, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cellsKeith A Cengel, K Rahn Voong, Sanjay Chandrasekaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2013
Lessons learned from radiation oncology clinical trialsFei-Fei Liu, , Paul Okunieff, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Pageof 25

Showing results (171-180 of 250) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
The measurement of bioreductive capacity of tumor cells using methylene blueJ E Biaglow, C J Koch, S W Tuttle, et al.
Cancer Research|May 8, 2007
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavirZibin Jiang, Nabendu Pore, George J Cerniglia, et al.
Cancer Research|February 24, 2001
Apoptosis: an early event in metastatic inefficiencyC W Wong, A Lee, L Shientag, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, A Ravaud, Y Grassano, et al.
Gastroenterology|July 6, 2004
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogeneFranz S Schreiber, Therese B Deramaudt, Thomas B Brunner, et al.
Cancer Research|September 20, 2006
Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapyNabendu Pore, Anjali K Gupta, George J Cerniglia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]J Bernhard, G Capon, G Pierquet, et al.
Neoplasia (New York, N.Y.)|April 27, 2007
Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cellsKeith A Cengel, K Rahn Voong, Sanjay Chandrasekaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2013
Lessons learned from radiation oncology clinical trialsFei-Fei Liu, , Paul Okunieff, et al.
Statistics in Medicine|April 29, 1998
Missing quality of life data in cancer clinical trials: serious problems and challengesJ Bernhard, D F Cella, A S Coates, et al.
Pageof 25